Back to stocks
EIKN

EIKN

Eikon Therapeutics, Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
17
Partial Q3 2026
Total 13F value
$5.6M
Filed positions so far
New positions
9
This quarter
Sold positions
1
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Regents Of The University Of California

$5.1M635.1K0.08%New Position

Y-Intercept (Hong Kong) Ltd

$163K20.3K0.00%New Position

Proshare Advisors Llc

$127K15.8K0.00%-46.9%

Creative Planning

$82K10.2K0.00%New Position

Pavaki Capital Management Llc

$80K10.0K0.03%New Position

Ifp Advisors, Inc

$8K9690.00%+5.6%

Sterling Capital Management Llc

$7K9210.00%+384.7%

State Of Wyoming

$3K3630.00%-33.9%

Farther Finance Advisors, Llc

$1K1490.00%New Position

Aspect Partners, Llc

$1K1400.00%+11.1%

Gamma Investing Llc

$1K1280.00%New Position

Fortitude Family Office, Llc

$9731210.00%Unchanged

True Wealth Design, Llc

$362450.00%New Position

Caitong International Asset Management Co., Ltd

$137170.00%+325.0%

Essential Partners Llc

$121150.00%New Position

Sjs Investment Consulting Inc.

$4960.00%New Position

Sbi Securities Co., Ltd.

$1620.00%Unchanged

Explore